AnodyneWiki

Dimethyltryptamine

DMT, N,N-DMT
Dimethyltryptamine
Salts
[]
Dimethyltryptamine fumarate
Dimethyltryptamine fumarate
Dimethyltryptamine hydrochloride
Dimethyltryptamine hydrochloride
Molecular structure drawn from PubChem coordinates
Physical properties
[]
Molecular mass188.27 g/mol [1]
AppearanceCrystals ... also reported as plates from ethanol and light petroleum [1]
Melting point46 °C [1]
Boiling point60-80 °C [1]
DecompositionWhen heated to decomposition if emits toxic fumes of /nitrogen oxides/. [1]
SolubilityFreely soluble in dilute acetic and dilute mineral acids [1]
Predicted LogP2.5 [1]
Structural Identifiers
[]
Molecular formulaC12H16N2
IUPAC name2-(1H-indol-3-yl)-N,N-dimethylethanamine
SMILESCN(C)CCC1=CNC2=CC=CC=C21
InChIInChI=1S/C12H16N2/c1-14(2)8-7-10-9-13-12-6-4-3-5-11(10)12/h3-6,9,13H,7-8H2,1-2H3
InChIKeyDMULVCHRPCFFGV-UHFFFAOYSA-N
CAS number61-50-7
UNIIWUB601BHAA
PubChem CID6089
Pharmacokinetics[]
Onset* Inhalation: 10–15 seconds * Intravenous: ≤2–5 min * Intramuscular: 2–5 min * Oral with monoamine oxidase inhibitor: ≤1 hour
Elimination half-life* Alone: 5–19 min * With monoamine oxidase inhibitor: 1–4 hours[3]
Duration of action* Inhalation: ≤15 min * Intravenous: ≤30 min * Intramuscular: 30–60 min * Oral with monoamine oxidase inhibitor: 4–6 hours[4]
MetabolismOxidative deamination (Monoamine oxidase A), N-oxidation, N-demethylation, peroxidation
ExcretionUrine
Routes of administrationOral (with monoamine oxidase inhibitor), inhalation (smoking or vaping), intramuscular, subcutaneous, intravenous (bolus or infusion)
Dependence liabilityNone or very low
Addiction liabilityNone or very low
Toxicity
[]
Mouse:
- iv: 32 mg/kg
- ip: 47 mg/kg
 [1]
Dosing[]
Insufflated
[]
Light≤ 62.5 mg(1x - 50.0%)
Common62.5 - 75 mg
Strong75 - 87.5 mg
Heavy87.5 - 95 mg
Extreme95 mg +(1x - 50.0%)
Oral
[]
Light≤ 65.1 mg(1x - 50.0%)
Common65.1 - 130.1 mg
Strong130.1 - 195 mg
Heavy195 - 234 mg
Extreme234 mg +(1x - 50.0%)
Vaporized
[]
Light≤ 21.9 mg(2x - 40.0%)
Common21.9 - 30 mg(1x - 20.0%)
Strong30 - 45 mg(1x - 20.0%)
Heavy45 - 48 mg
Extreme48 mg +(1x - 20.0%)
Statistically derived dosages via DBI-IGS (archived by anodyne.wiki)
We do not take any responsibility for medical complications or loss of life sustained by following these dosages blindly.

Dimethyltryptamine (also known as 2-(3-Indolyl)ethyldimethylamine, 3-(2-Dimethylaminoethyl)indole, 1H-Indole-3-ethanamine, N,N-dimethyl-, N,N-Dimethyl-1H-indole-3-ethylamine, DEA No. 7435, 3-[2-(dimethylamino)ethyl]indole, [2-(1H-indol-3-yl)ethyl]dimethylamine, 3-(2-(dimethylamino)ethyl)indole, (2-(1H-indol-3-yl)ethyl)dimethylamine or N,N Dimethyltryptamine) is a antidepressant, depressant and psychedelic substance of the tryptamine class.

Chemistry

Salts []

Dimethyltryptamine is typically found in the form of its fumarate and hydrochloride salts.

 []

Dimethyltryptamine is achiral.

Dimethyltryptamine matches Lipinski's rule of five.

There are currently 9 reagent-interactions on

ReagentColor changeDescription
Marquisyellow > orange > brown
Meckebrown / green
Mandelin(faint) green > brown
Liebermannbrown > black
Froehdeno color change
Robadopeno pink color change
Simon'sBlack precipitates with Simon A, no change with B
Ehrlichpink > magenta / red
Hofmannyellow

Pharmacology

Mechanism of action []

DMT acts as a non-selective agonist at most or all of the serotonin receptors. [1]

Subjective effects []

0xea / Dimethyltryptamine []
Routes:
  • Vaporized (15 - 30mg)
    Onset: 15 s
    Comeup: 30 s
    Duration: 3 m
Effects:Notes:
  • ~15mg vaporized produced very light effects but made me leave with newfound meaning and motivation
  • ~20mg vaporized produced feelings of shooting through space while completely clear in my head, very clean beautiful visuals
  • ~25mg vaporized produced feelings of being torn out of my body and lost in space
magnus / Dimethyltryptamine []
Routes:
  • Vaporized
Notes:
  • smoked off foil; visuals present; breakthrough when combined with lsd and ketamine (although I don’t remember anything much)
Mere / Dimethyltryptamine []
nervewing / Dimethyltryptamine []
x86pup / Dimethyltryptamine []
Routes:
  • Vaporized

Experience reports

Erowid

There are currently 30 experience reports involving dimethyltryptamine on : []

Reddit

There are currently 50 trip reports involving dimethyltryptamine on : []

 []

  • Australia: Dimethyltryptamine is a Schedule 9.
  • Canada: Dimethyltryptamine is a Schedule III.
  • United Kingdom: Dimethyltryptamine is a Class A under the "Misuse of Drugs Act 1971".
  • United States: Dimethyltryptamine is a Schedule I under the "Controlled Substances Act".
  • Germany: Dimethyltryptamine is a Anlage I under the "Betäubungsmittelgesetz (BtMG)".
  • Brazil: Dimethyltryptamine is a F2.[5]
  • United Nations: Dimethyltryptamine is a Schedule I psychotropic under the "Convention on Psychotropic Substances 1971".
  • European Union: Dimethyltryptamine is a Illegal.
  • Other: Dimethyltryptamine is a SE: Illegal.

See also []

External links []

References []

  1. National Center for Biotechnology Information. PubChem Compound Summary for CID 6089, Dimethyltryptamine. Accessed November 20, 2026. https://pubchem.ncbi.nlm.nih.gov/compound/6089
  2. U.S. Food and Drug Administration; National Center for Advancing Translational Sciences. Dimethyltryptamine. UNII: WUB601BHAA. Global Substance Registration System. Accessed November 20, 2026. https://gsrs.ncats.nih.gov/ginas/app/beta/substances/WUB601BHAA
  3. Vollebregt R, Storm AE, Lucassen PJ, Somers M. Psychedelic Experiences Elicited by Serotonergic Psychedelics; Molecular Mechanisms and Functional Connectivity Changes in /the Brain. Neuroscience and Biobehavioral Reviews. December 2025; 181(). PMID 41412413.
  4. Barker SA. Administration of N,N-dimethyltryptamine (DMT) in psychedelic therapeutics and research and the study of endogenous DMT. Psychopharmacology. June 2022; 239(6):1749–1763. PMID 35064294. https://doi.org/10.1007/s00213-022-06065-0
  5. RDC Nº 804 - Listas de Substâncias Entorpecentes, Psicotrópicas, Precursoras e Outras sob Controle Especial. Diário Oficial da União. 24 July 2023. https://www.in.gov.br/en/web/dou/-/resolucao-rdc-n-804-de-24-de-julho-de-2023-498447451

Data sources []

SourceStatusUpdated (UTC)
dosingok2026-11-20 09:11:02
drugsprook2026-11-20 09:10:57
erowidok2026-11-20 09:11:04
gsrsok2026-11-20 09:10:59
hmdbmissing (hmdb.ca refused automated access to HMDB0005973)2026-11-20 09:10:57
keggok2026-11-20 09:10:59
pubchemok2026-11-20 09:10:57
redditok2026-11-20 09:10:57
sidermissing (not in SIDER)2026-11-20 09:10:57
structureok2026-11-20 09:10:57
wikipediaok2026-11-20 09:10:58